Skip to main content

Security report for clinicalresearchnewsonline.com

Clinical Research News · Healthcare · United States

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

64/100

Risk levelMedium

0–100, higher is better. How it is calculated

Clinical Research News Online is a specialized digital publication focused on delivering news, analysis, and insights related to clinical trials, patient recruitment, and clinical research technologies. It operates under the umbrella of Cambridge Innovation Institute, a reputable organization in the healthcare and life sciences sector. The website targets professionals in clinical research, pharmaceutical companies, and healthcare providers, offering a range of services including news articles, press releases, advertising, webinars, and podcasts. The business model is primarily advertising and lead generation driven, supported by event promotion and content marketing. Technically, the website is built on the Sitefinity CMS platform, utilizing modern web technologies such as Bootstrap for responsive design, Google Tag Manager for analytics, and integration with social media platforms. The site demonstrates good mobile optimization and SEO practices, although accessibility features are basic. Performance is moderate, with no critical technical issues detected. From a security perspective, the site enforces HTTPS and implements a cookie consent mechanism aligned with GDPR requirements. However, it lacks several recommended security headers and does not publish explicit security policies or incident response contacts. No vulnerabilities or exposed sensitive data were detected in the analysis. The absence of WHOIS registration data for the domain is a notable concern, potentially indicating privacy protection or a WHOIS query limitation, which slightly impacts the trustworthiness assessment. Overall, Clinical Research News Online presents as a professional and credible source within its niche, with a solid technical foundation and privacy compliance. Strategic recommendations include enhancing security headers, publishing security and incident response policies, and resolving WHOIS data inconsistencies to improve domain legitimacy and trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching clinicalresearchnewsonline.com

This scan found 27 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
15
Email security
75
DNS health
75
Network security
100
GDPR outside view
53
Average
64

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website occupies a niche position in the healthcare media market, focusing on clinical research news and analysis. Its competitive advantage lies in its specialized content and association with Cambridge Innovation Institute, which lends credibility and access to industry networks. Revenue streams appear to be diversified across advertising, lead generation, sponsored content, and event promotion. The target customer segments include clinical researchers, pharmaceutical companies, CROs, and healthcare professionals. Growth indicators include active content updates, social media engagement, and integration with industry events and webinars. The partnership ecosystem includes related Cambridge Innovation Institute divisions and external advertising networks. Operationally, the site maintains a professional digital presence with moderate technical sophistication and compliance with privacy regulations.

Security posture

The website demonstrates a moderate to good security posture with mandatory HTTPS encryption and a functional cookie consent mechanism supporting GDPR compliance. However, the absence of additional security headers such as Content-Security-Policy, X-Content-Type-Options, and Strict-Transport-Security reduces its defense-in-depth capabilities. No security.txt or vulnerability disclosure policy is published, limiting transparency for security researchers. Incident response contact information is not provided, which could delay response to security incidents. No exposed credentials or sensitive data were found, and no vulnerable libraries were detected. Overall, the security maturity is adequate for a media website but could be improved to meet higher standards and regulatory expectations.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Content-Type-Options, and Strict-Transport-Security to enhance protection against common web attacks.
  2. Publish a clear security policy and incident response contact information to improve transparency and readiness for security incidents.
  3. Establish a vulnerability disclosure program or security.txt file to facilitate responsible reporting of security issues.
  4. Verify and correct WHOIS domain registration data to improve domain legitimacy and trustworthiness.
  5. Enhance accessibility features to improve compliance with accessibility standards and broaden audience reach.

Contact details published on the site

Addresses
Legal name
Cambridge Innovation Institute
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Clinical Research News
Description
Clinical Research News is your source for news on clinical trial technologies, ePRO, and patient recruitment. Discover the future of clinical research.
Key services
News articles, Press releases, Advertising opportunities, Lead generation, Webinars, Podcasts, Whitepapers, Event promotion
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, jQuery, Google Tag Manager, Google Ads, Twitter Widgets, Sitefinity CMS, Bootstrap CSS
Frameworks
Bootstrap
Platforms
Sitefinity CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data detected

Analytics and tracking

Services
Google Analytics (via Google Tag Manager), Sitefinity Insight
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Google DoubleClick
Tracking pixels
LinkedIn Insight Tag, Twitter Widgets
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF detected
  2. Professional and consistent branding linked to Cambridge Innovation Institute
  3. Comprehensive cookie consent and privacy policy present
  4. No visible security headers beyond HTTPS
  5. WHOIS data unavailable, raising domain legitimacy questions
  6. Multiple social media and partner links consistent with business profile
  7. Advertising and analytics implemented via Google and LinkedIn
  8. No contact forms detected on homepage; contact info in footer only
  9. No explicit terms of service or security policy pages found
Technical notes

Notes

The website is built on the Sitefinity CMS platform, leveraging Bootstrap for responsive design and jQuery for client-side scripting. It integrates Google Tag Manager and Google Ads for analytics and advertising, as well as Twitter widgets for social media content. The site uses asynchronous loading for scripts to improve performance. The HTML and CSS are valid and well-structured, supporting good SEO and mobile responsiveness. However, the site lacks advanced accessibility features and some modern security headers. Performance is moderate, with room for optimization in loading times and resource management. The technical infrastructure is stable and suitable for the site's content delivery needs but could benefit from modernization and enhanced security practices.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with clinicalresearchnewsonline.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review clinicalresearchnewsonline.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.